Testosterone can be injected subcutaneously using a standard insulin syringe, typically a 25- to 29-gauge needle that is half an inch or shorter. This approach deposits the medication into the fat layer just beneath the skin rather than deep into muscle, and research shows it produces testosterone levels comparable to traditional intramuscular injections. The technique has gained traction in clinical practice over the past decade, with growing evidence that it is not only effective but may carry some practical advantages worth understanding.
Why an Insulin Needle Works for Testosterone
Traditional testosterone injections use a 1- to 1.5-inch needle, typically 21 to 23 gauge, to reach deep muscle tissue in the thigh or gluteal area. An insulin syringe, by contrast, has a much shorter and thinner needle, usually 27 to 31 gauge and 5/16 to 1/2 inch long. That length is enough to reach the subcutaneous fat layer but not the muscle underneath, which changes the route of absorption but not the end result in your bloodstream.
Multiple studies have confirmed that subcutaneous testosterone delivery achieves blood levels in the same range as intramuscular injection. A review in the Journal of Clinical Endocrinology and Metabolism found that subcutaneous testosterone therapy at doses similar to those used intramuscularly produces comparable average serum testosterone levels and pharmacokinetics.1PubMed Central. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option A head-to-head comparison of men receiving intramuscular testosterone cypionate versus subcutaneous testosterone enanthate found that both groups saw significant increases in trough testosterone, with the route of administration not independently associated with testosterone levels.2PubMed. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate A pharmacokinetic study of subcutaneous testosterone enanthate also demonstrated that both 50 mg and 100 mg doses achieved normal testosterone concentrations, with low variation compared to 200 mg intramuscular injections.3PubMed Central. Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study
A pilot study comparing the two routes directly in the same patients found that total testosterone exposure was comparable, though there was wide variability between individuals regardless of the route used.4American Journal of Health-System Pharmacy. Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study In practical terms, if your dose and frequency are dialed in, the needle you use to deliver the testosterone is not what determines your blood levels.
Picking the Right Needle and Syringe
Not every insulin syringe is ideal for testosterone. The two things that matter most are gauge (the needle’s diameter) and length. For subcutaneous testosterone injection, most clinicians recommend a 25- to 27-gauge needle that is 1/2 inch long. Some people use 29-gauge needles successfully, but thinner needles mean more resistance when pushing oil-based testosterone through them. One study on injection mechanics found that moving from a 29-gauge to a 27-gauge needle reduced the force required to push a viscous fluid by about 59 percent.5PubMed. Improving prefilled syringe injectability: influences of critical component attributes and human factors Testosterone cypionate and enanthate are dissolved in oil, so they are significantly thicker than the water-based insulin these syringes were designed for. A 27-gauge needle strikes a reasonable balance between comfort and practicality.
Syringe volume also matters. Standard insulin syringes come in 0.3 mL, 0.5 mL, and 1 mL sizes. Since subcutaneous testosterone doses are usually smaller and more frequent than intramuscular doses, a 0.5 mL or 1 mL syringe covers most protocols. If your dose per injection is 0.25 mL or less, a 0.5 mL syringe gives you more precise markings to measure with.
Needle length needs to be long enough to clear the skin and reach the fat layer without going into muscle. Research on skin and subcutaneous tissue thickness has found that average skin thickness while sitting is about 3.3 mm, and that people with higher BMI tend to have thinner skin but thicker subcutaneous fat.6PubMed Central. Investigation of appropriate needle length considering skin thickness with the real injection posture for insulin injections in diabetic patients For most adults, a 1/2-inch needle inserted at a 90-degree angle lands squarely in subcutaneous tissue, especially at common injection sites like the abdomen or thigh. One study on needle lengths concluded that 4- to 5-mm needles are appropriate for abdominal injection at a right angle without risk of going too deep or staying too shallow.7Diabetes & Metabolism Journal. The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thickness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes If you are very lean with minimal abdominal fat, a 45-degree angle or a pinch of skin can help keep the injection subcutaneous.
Where to Inject
The two most common sites for subcutaneous testosterone injection are the lower abdomen (below the navel and to either side, avoiding the belt line and the two-inch zone directly around the navel) and the outer upper thigh. Both areas typically have enough subcutaneous fat for comfortable injection, and both are easy to reach when self-injecting.
The abdomen is the most frequently recommended site in clinical studies. It has a relatively consistent fat layer in most adults, and the area is large enough that you can rotate injection spots easily. The outer thigh works well too, particularly if you prefer not to inject near your stomach. Rotating between sites and between sides helps prevent localized irritation or the buildup of small nodules under the skin.
Avoid areas with visible veins, scars, stretch marks, or skin that is irritated or bruised. The goal is a clean patch of skin with a bit of subcutaneous tissue underneath.
Step by Step
Before you start, gather your supplies: the testosterone vial, an alcohol swab, your insulin syringe, and a sharps container for disposal. Wash your hands thoroughly.
- Warm the oil: Roll the testosterone vial between your palms for a minute or two. Warming the oil slightly reduces its viscosity and makes it easier to draw into a thin needle. Do not microwave or heat it with hot water to the point that it is uncomfortable to touch.
- Clean the vial: Wipe the rubber stopper of the vial with an alcohol swab and let it air dry.
- Draw air: Pull back the plunger on your insulin syringe to the volume you plan to inject. Insert the needle through the rubber stopper and push the air into the vial. This equalizes pressure inside the vial and makes drawing easier.
- Draw the testosterone: Turn the vial upside down with the needle still inside. Pull the plunger back slowly past your target dose. Drawing slightly extra lets you tap out air bubbles and then push the plunger forward to your exact dose, expelling the air in the process.
- Prepare the site: Swab the injection area with alcohol and let it dry completely.
- Inject: If you have a moderate amount of body fat at the site, insert the needle straight in at 90 degrees. If you are very lean, pinch a fold of skin and fat with your free hand and insert the needle at a 45-degree angle into the fold. Push the plunger slowly and steadily. There is no need to aspirate (pull back on the plunger to check for blood) with subcutaneous injections.
- Withdraw: Pull the needle out at the same angle you inserted it. If there is a small drop of blood or oil at the surface, press lightly with a cotton ball or gauze for a few seconds. Do not rub the area.
The entire injection typically takes under a minute once you have practiced it a few times. Because the needle is so small, many people report feeling little more than a brief pinch.
Dealing With Thick Oil and Slow Draw Times
The biggest practical complaint about using insulin needles for testosterone is the time it takes to draw oil through a narrow-gauge needle. With a 27- or 29-gauge needle, drawing 0.3 to 0.5 mL of testosterone cypionate can take 30 seconds to over a minute, and the plunger can feel stiff. A few strategies help:
Some people use a separate, larger-gauge needle (such as an 18-gauge drawing needle) to fill the syringe, then swap to the insulin needle for the actual injection. This works if your insulin syringe has a detachable needle. Many insulin syringes, however, have fixed needles, meaning you are stuck drawing through the same thin needle you inject with. In that case, warming the oil and injecting air into the vial (as described above) are your main tools for making the draw less tedious.
Patience matters more than force. Yanking the plunger back hard can introduce large air bubbles or cause the plunger to pull free from the barrel. Slow, steady pressure draws the oil cleanly. If the plunger becomes very difficult to pull, check that the needle tip is fully submerged in the oil and that the bevel is not pressed against the side of the vial.
Dosing and Injection Frequency
Subcutaneous injection lends itself to smaller, more frequent doses rather than the large, less frequent intramuscular injections that have been standard for decades. A typical intramuscular protocol might call for 100 to 200 mg every one to two weeks. Subcutaneous protocols often split that into smaller doses given twice a week or even every other day. This is partly a volume issue, since injecting a full milliliter of oil subcutaneously can be uncomfortable, and partly because more frequent dosing produces more stable blood levels.
Research on subcutaneous testosterone has found that levels remain remarkably steady between injections when patients are on a consistent schedule. In one study, men receiving weekly subcutaneous doses had total testosterone that stayed well within the normal range throughout the entire interval between shots, with an overall mean of about 627 ng/dL and no adverse effects reported.8PubMed Central. Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone That stability contrasts with the rollercoaster pattern often seen with biweekly intramuscular injections, where levels spike shortly after the shot and drop toward the low end before the next one. Flatter levels can translate into fewer mood swings, more consistent energy, and fewer symptoms in the days before your next injection.
Your prescriber will determine the specific dose and frequency. If you are transitioning from an intramuscular protocol to subcutaneous, the total weekly milligram amount usually stays similar or is adjusted slightly based on lab work after the switch.
Potential Advantages of the Subcutaneous Route
Beyond comfort, there is evidence suggesting subcutaneous injection may have a couple of clinically meaningful benefits. One concern with testosterone replacement is erythrocytosis, an increase in red blood cell concentration that can raise the risk of blood clots. A study of men with low testosterone found that subcutaneous testosterone cypionate appeared to produce a lower rate of erythrocytosis compared to rates reported for intramuscular injection in the literature.9The Journal of Sexual Medicine. Erythrocytosis in Subcutaneous Testosterone Replacement Therapy However, a separate analysis comparing hematocrit levels directly between the two routes found no significant difference after treatment.10The Journal of Sexual Medicine. Investigating the Effect of Intramuscular Versus Subcutaneous Testosterone on Hematocrit Levels The evidence is mixed, and your doctor will still monitor your blood counts regardless of route.
The comparison study mentioned earlier also found that subcutaneous testosterone enanthate was independently associated with lower estradiol levels after treatment, which may be relevant for men who experience estrogen-related side effects on testosterone therapy.2PubMed. Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate Whether this translates into fewer symptoms like water retention or breast tenderness is not fully established, but it is an interesting signal.
Patient Preference and Adherence
Self-injecting testosterone is a long-term commitment, and how tolerable the process feels day to day directly affects whether people stick with it. A review of the data noted that with appropriate training, patients can safely self-administer testosterone subcutaneously with relative ease and less discomfort compared to the intramuscular route.1PubMed Central. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option That same review highlighted that long-term compliance with intramuscular testosterone injections is strikingly low: roughly 69 percent of men on long-acting intramuscular esters discontinue treatment within three months, and 95 percent stop within a year. By making injections easier, less painful, and possible at home without help, subcutaneous delivery with an insulin needle may help more people stay on therapy. Studies that have assessed patient preference generally find that those who have tried both routes prefer subcutaneous, and transgender men who switched from intramuscular to subcutaneous did not want to switch back.
Overall satisfaction with injectable testosterone is reasonably high. A survey of men on various testosterone formulations found that about 73 percent of those using injections reported satisfaction with their treatment.11PubMed Central. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices Route of injection was not broken out separately in that survey, but the finding suggests that the injection process itself is not the primary driver of dissatisfaction for most users.
Safe Needle Disposal
Used insulin needles are sharps waste, and they need to go into a puncture-resistant sharps container, not the regular trash. You can buy FDA-cleared sharps containers at most pharmacies for a few dollars, or use a heavy-duty plastic container like a laundry detergent jug with a screw-on lid. Never recap a used needle by pushing the cap back on with your other hand; if you recap, use a one-handed scoop technique to avoid sticking yourself.
Safe disposal is something many home injectors get wrong. A study of patients injecting insulin at home found that only about 10 percent disposed of their needles safely, and fewer than 15 percent had ever received instructions on proper sharps disposal.12PubMed Central. At-home disposal practices of used insulin needles among patients with diabetes in China: A single-center, cross-sectional study When your sharps container is about three-quarters full, seal it and check your local regulations for disposal options. Many pharmacies, hospitals, and waste management programs accept filled sharps containers. Some municipalities offer mail-back programs as well.
When Subcutaneous Injection May Not Be the Best Choice
Subcutaneous testosterone injection with an insulin needle works well for most people, but a few situations call for caution. If your prescribed single-injection volume is large (over about 0.5 mL), subcutaneous injection can be uncomfortable and may leave a noticeable lump under the skin that takes longer to absorb. Splitting the dose across two injection days per week usually solves this, but not everyone wants to inject that frequently.
People with very little subcutaneous fat at accessible injection sites may have difficulty keeping the injection out of muscle, even with a short needle. Body composition data shows that subcutaneous fat thickness varies by site, sex, and BMI.13PubMed. Subcutaneous adipose tissue thickness in adults – correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection If you are very lean, injecting into the abdomen with a pinch of skin is usually the safest approach, since even lean individuals tend to carry some fat there.
Certain testosterone formulations are specifically designed for intramuscular use and come in volumes or concentrations that do not adapt well to subcutaneous delivery. Testosterone undecanoate (the long-acting formulation given every ten weeks or so) is administered in a 3 mL or 4 mL volume and is not appropriate for an insulin syringe. The subcutaneous insulin-needle technique applies to testosterone cypionate and testosterone enanthate, which are the formulations commonly prescribed for at-home self-injection.
Finally, while the evidence supports subcutaneous testosterone as a reasonable option, it remains technically off-label in many countries. Your prescriber may or may not be familiar with the approach, and some pharmacies may question a prescription that specifies insulin syringes for testosterone. Having a conversation with your provider about the published evidence can smooth the process if you encounter resistance.